Simultaneous confidence band for the difference of segmented linear modelsYOTHERS, Greg; SAMPSON, Allan R.Journal of statistical planning and inference. 2011, Vol 141, Num 2, pp 1059-1068, issn 0378-3758, 10 p.Article

ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon CancerRENFRO, Lindsay A; GROTHEY, Axel; YOTHERS, Greg et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 12, issn 0027-8874, 333.1-333.9Article

Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus LeucovorinO'CONNELL, Michael J; LAVERY, Ian; COWENS, J. Wayne et al.Journal of clinical oncology. 2010, Vol 28, Num 25, pp 3937-3944, issn 0732-183X, 8 p.Article

End points for colon cancer adjuvant trials : Observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT groupSARGENT, Daniel J; PATIYIL, Smitha; FRANCINI, Guido et al.Journal of clinical oncology. 2007, Vol 25, Num 29, pp 4569-4574, issn 0732-183X, 6 p.Article

Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data SetHUBBARD, Joleen; THOMAS, David M; SARGENT, Daniel et al.Journal of clinical oncology. 2012, Vol 30, Num 19, pp 2334-2339, issn 0732-183X, 6 p.Article

Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon CancerALLEGRA, Careen J; YOTHERS, Greg; FEHRENBACHER, Louis et al.Journal of clinical oncology. 2009, Vol 27, Num 20, pp 3385-3390, issn 0732-183X, 6 p.Article

Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancerDIGNAM, James J; POLITE, Blase N; YOTHERS, Greg et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 22, pp 1647-1654, issn 0027-8874, 8 p.Article

HER2 and choice of adjuvant chemotherapy for invasive breast cancer : National Surgical Adjuvant Breast and Bowel Project Protocol B-15PAIK, Soonmyung; BRYANT, John; TAN-CHIU, Elizabeth et al.Journal of the National Cancer Institute. 2000, Vol 92, Num 24, pp 1991-1998, issn 0027-8874Article

Body Mass Index at Diagnosis and Survival Among Colon Cancer Patients Enrolled in Clinical Trials of Adjuvant ChemotherapySINICROPE, Frank A; FOSTER, Nathan R; YOTHERS, Greg et al.Cancer. 2013, Vol 119, Num 8, pp 1528-1536, issn 0008-543X, 9 p.Article

Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08POGUE-GEILE, Kay; YOTHERS, Greg; ALLEGRA, Carmen et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 13, pp 989-992, issn 0027-8874, 4 p.Article

Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus OxaliplatinYOTHERS, Greg; O'CONNELL, Michael J; LEE, Mark et al.Journal of clinical oncology. 2013, Vol 31, Num 36, pp 4512-4519, issn 0732-183X, 8 p.Article

Primary mFOLFOX6 Plus Bevacizumab Without Resection of the Primary Tumor for Patients Presenting With Surgically Unresectable Metastatic Colon Cancer and an Intact Asymptomatic Colon Cancer: Definitive Analysis of NSABP Trial C-10MCCAHILL, Laurence E; YOTHERS, Greg; WAGMAN, Lawrence D et al.Journal of clinical oncology. 2012, Vol 30, Num 26, pp 3223-3228, issn 0732-183X, 6 p.Article

Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03ROH, Mark S; COLANGELO, Linda H; WOLMARK, Norman et al.Journal of clinical oncology. 2009, Vol 27, Num 31, pp 5124-5130, issn 0732-183X, 7 p.Article

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07KUEBLER, J. Philip; WIEAND, H. Samuel; ZAPAS, John L et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2198-2204, issn 0732-183X, 7 p.Article

Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT DatabaseQIAN SHI; ANDRE, Thierry; O'CONNELL, Michael J et al.Journal of clinical oncology. 2013, Vol 31, Num 29, pp 3656-3663, issn 0732-183X, 8 p.Article

Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy TrialsSINICROPE, Frank A; FOSTER, Nathan R; YOON, Harry H et al.Journal of clinical oncology. 2012, Vol 30, Num 4, pp 406-412, issn 0732-183X, 7 p.Article

Long-Term Neurotoxicity Effects of Oxaliplatin Added to Fluorouracil and Leucovorin as Adjuvant Therapy for Colon Cancer: Results from National Surgical Adjuvant Breast and Bowel Project Trials C-07 and LTS-01KIDWELL, Kelley M; YOTHERS, Greg; GANZ, Patricia A et al.Cancer. 2012, Vol 118, Num 22, pp 5614-5622, issn 0008-543X, 9 p.Article

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2-Positive Breast CancerROMOND, Edward H; JEONG, Jong-Hyeon; FLYNN, Patrick J et al.Journal of clinical oncology. 2012, Vol 30, Num 31, pp 3792-3799, issn 0732-183X, 8 p.Article

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset AnalysesYOTHERS, Greg; O'CONNELL, Michael J; ALLEGRA, Carmen J et al.Journal of clinical oncology. 2011, Vol 29, Num 28, pp 3768-3774, issn 0732-183X, 7 p.Article

Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer : NSABP B-31TAN-CHIU, Elizabeth; YOTHERS, Greg; VOGEL, Victor G et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7811-7819, issn 0732-183X, 9 p.Article

Real-world performance of HER2 testing: National Surgical Adjuvant Breast and Bowel Project ExperiencePAIK, Soomyung; BRYANT, John; WICKERHAM, D. Lawrence et al.Journal of the National Cancer Institute. 2002, Vol 94, Num 11, pp 852-854, issn 0027-8874, 3 p.Article

Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04O'CONNELL, Michael J; COLANGELO, Linda H; PARDA, David S et al.Journal of clinical oncology. 2014, Vol 32, Num 18, pp 1927-1934, issn 0732-183X, 8 p.Conference Paper

Bevacizumab in Stage II-III Colon Cancer: 5-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 TrialALLEGRA, Carmen J; YOTHERS, Greg; O'CONNELL, Michael J et al.Journal of clinical oncology. 2013, Vol 31, Num 3, pp 359-364, issn 0732-183X, 6 p.Article

Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT DatabaseMCCLEARY, Nadine J; MEYERHARDT, Jeffrey A; SARGENT, Daniel J et al.Journal of clinical oncology. 2013, Vol 31, Num 20, pp 2600-2606, issn 0732-183X, 7 p.Article

Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive ValueGAVIN, Patrick G; COLANGELO, Linda H; BLACKMON, Nicole L et al.Clinical cancer research (Print). 2012, Vol 18, Num 23, pp 6531-6541, issn 1078-0432, 11 p.Article